325 genotypes with 402 annotations displayed
of selected term and subterms
|
Searched Term: increased nervous system tumor incidence
|
Actn4tm1a(EUCOMM)Wtsi/Actn4tm1a(EUCOMM)Wtsi
(C57BL/6N-Actn4tm1a(EUCOMM)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Acvr1tm1Mak/Acvr1+ Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+ H3c2tm1Mak/H3c2+ Olig2tm1.1(cre)Wdr/Olig2+
(involves: 129 * C57BL/6 * FVB/N)
|
increased brain tumor incidence
|
J:285841
|
increased glioma incidence
|
J:285841
|
Acvr1tm1Mak/Acvr1+ Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+ Olig2tm1.1(cre)Wdr/Olig2+
(involves: 129 * C57BL/6 * FVB/N)
|
increased brain tumor incidence
|
J:285841
|
increased glioma incidence
|
J:285841
|
Adamts3tm1b(KOMP)Wtsi/Adamts3tm1b(KOMP)Wtsi
(C57BL/6N-Adamts3tm1b(KOMP)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Aicdatm1(cre)Mnz/Aicda+ Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
increased medulloblastoma incidence
|
J:153656
|
AipGt(RRI002)Byg/Aip+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pituitary adenoma incidence
|
J:165349
|
increased prolactinoma incidence
|
J:165349
|
Alktm1.1(ALK*F1174L)Heno/Alk+ Tg(Mpz-cre)94Imeg/0 Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6 * SJL)
|
increased neuroblastoma incidence
|
J:294092
|
Alktm1.1(ALK*F1174L)Heno/Alktm1.1(ALK*F1174L)Heno Tg(Mpz-cre)94Imeg/0 Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6 * SJL)
|
increased neuroblastoma incidence
|
J:294092
|
Alktm1.1Ics/? Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6J)
|
increased neuroblastoma incidence
|
J:261033,
J:228124
|
Alktm2.1Ics/? Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6J)
|
increased neuroblastoma incidence
|
J:261033,
J:228124
|
Atp11atm1a(KOMP)Wtsi/Atp11atm1a(KOMP)Wtsi
(C57BL/6N-Atp11atm1a(KOMP)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Brca2tm1Brn/Brca2tm1Brn Ptch1tm1Mps/Ptch1+ Trp53tm1Tyj/Trp53+ Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:144617
|
Brca2tm1Brn/Brca2tm1Brn Ptch1tm1Mps/Ptch1+ Trp53tm1Tyj/Trp53tm1Tyj Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:144617
|
Brca2tm1Brn/Brca2tm1Brn Trp53tm1Tyj/Trp53+ Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:144617
|
Brca2tm1Brn/Brca2tm1Brn Trp53tm1Tyj/Trp53tm1Tyj Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:144617
|
Brip1Gt(RRI409)Byg/Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd)
|
increased pituitary adenoma incidence
|
J:227115
|
Bub1tm1.1Tvd/Bub1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased brain tumor incidence
|
J:143035
|
Capza2tm1b(KOMP)Wtsi/Capza2tm1b(KOMP)Wtsi
(C57BL/6N-Capza2tm1b(KOMP)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Ccnd1tm1Dsn/Ccnd1tm1Dsn Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129 * C57BL/6)
|
increased pituitary adenoma incidence
|
J:66707
|
Cdk4tm1.1Bbd/Cdk4+ Krastm1Bbd/Kras+ Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
increased pituitary adenoma incidence
|
J:86101
|
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:50053
|
Cdkn1btm1Ako/Cdkn1btm1Ako Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(involves: 129/Sv * 129S1/Sv * C57BL/6 * DBA/2)
|
increased pituitary adenoma incidence
|
J:50053
|
Cdkn1btm1Ako/Cdkn1btm1Ako Men1tm1.1Ctre/Men1+
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:120835
|
Cdkn1btm1Kin/Cdkn1btm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pituitary adenoma incidence
|
J:33402
|
Cdkn1btm1Mlf/Cdkn1b+ Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
increased medulloblastoma incidence
|
J:205254
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J)
|
increased pituitary adenoma incidence
|
J:33400
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
increased medulloblastoma incidence
|
J:205254
|
Cdkn1btm2Mlf/Cdkn1btm2Mlf Tg(Pomc1-cre)1Mlf/0
(involves: 129S4/SvJaeSor)
|
increased pituitary gland tumor incidence
|
J:107588
|
Cdkn1btm3Mlf/Cdkn1btm3Mlf
(involves: 129S4/SvJaeSor)
|
increased pituitary gland tumor incidence
|
J:107588
|
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd * FVB/N)
|
increased meningioma incidence
|
J:131179
|
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn Nf2tm2Gth/Nf2tm2Gth Ptgdstm1.1(cre)Gvn/Ptgds+
(involves: 129P2/OlaHsd * FVB/N)
|
increased meningioma incidence
|
J:173718
|
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn Nf2tm2Gth/Nf2tm2Gth Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased Schwannoma incidence
|
J:132943
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs Tg(GFAP-TVA)5Hev/0
(involves: 129X1/SvJ * BALB/c * C57BL/6 * FVB/N)
|
increased glioma incidence
|
J:125535
|
increased oligodendroglioma incidence
|
J:125535
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs Tg(NES-TVA)J12Ech/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
increased glioma incidence
|
J:125535
|
increased oligodendroglioma incidence
|
J:125535
|
Cdkn2atm1Rdp/Cdkn2a+ Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * 129S6/SvEvTac)
|
increased neurofibrosarcoma incidence
|
J:131914
|
Cdkn2atm1Rdp/Cdkn2a+ Tg(NES-TVA)J12Ech/0
(involves: 129 * C57BL/6 * FVB/N * SJL)
|
increased glioma incidence
|
J:52161
|
Cdkn2atm1Rdp/Cdkn2a+ Tg(S100b-v-erbB)4496Waw/0
(involves: 129/Sv * C57BL/6J * DBA/2J * FVB/N * SJL)
|
increased glioma incidence
|
J:82649
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
increased brain tumor incidence
|
J:163931
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Col1a1tm1(CAG-EGFR)Char/Col1a1tm1(CAG-EGFR)Char Ptentm1Hwu/Ptentm1Hwu
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * SJL)
|
increased glioblastoma incidence
|
J:146494
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Col1a1tm1(CAG-EGFR)Char/Col1a1tm2(CAG-EGFR*)Char Ptentm1Hwu/Ptentm1Hwu
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * SJL)
|
increased glioblastoma incidence
|
J:146494
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Col1a1tm2(CAG-EGFR*)Char/Col1a1tm2(CAG-EGFR*)Char Ptentm1Hwu/Ptentm1Hwu
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * SJL)
|
increased glioblastoma incidence
|
J:146494
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * 129S6/SvEvTac)
|
increased neurofibrosarcoma incidence
|
J:131914
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Tg(GFAP-TVA)5Hev/0
(involves: 129/Sv * BALB/c * C57BL/6 * FVB/N * SJL)
|
increased glioma incidence
|
J:125535
|
increased oligodendroglioma incidence
|
J:125535
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Tg(GFAP-TVA)10Ech/0
(involves: 129 * BALB/c * C57BL/6 * FVB/N * SJL)
|
increased glioma incidence
|
J:52161
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Tg(NES-TVA)J12Ech/0
(involves: 129 * C57BL/6 * FVB/N * SJL)
|
increased glioma incidence
|
J:52161
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Tg(NES-TVA)J12Ech/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL)
|
increased glioma incidence
|
J:125535
|
increased oligodendroglioma incidence
|
J:153220
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp Tg(S100b-v-erbB)4496Waw/0
(involves: 129/Sv * C57BL/6J * DBA/2J * FVB/N * SJL)
|
increased glioma incidence
|
J:82649
|
increased oligodendroglioma incidence
|
J:82649
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp Tg(GFAP-TVA)5Hev/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * FVB/N)
|
increased glioma incidence
|
J:125535
|
increased oligodendroglioma incidence
|
J:125535
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp Tg(NES-TVA)J12Ech/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased glioma incidence
|
J:125535
|
increased oligodendroglioma incidence
|
J:125535
|
Cdkn2atm2Brn/Cdkn2atm2Brn Tg(Tyr-cre/ERT,-Hras1*,-Trap1a)10BJvde/0
(involves: C57BL/6 * FVB/N)
|
increased neurofibrosarcoma incidence
|
J:107175
|
Cdkn2atm4Rdp/Cdkn2atm4Rdp Nf1tm1Par/Nf1tm1Par
(involves: 129S1/Sv * 129X1/SvJ)
|
increased neurofibrosarcoma incidence
|
J:234760
|
Cdkn2btm1Bbd/Cdkn2btm1Bbd Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
increased pituitary adenoma incidence
|
J:63299
|
Cdkn2ctm1Bbd/Cdkn2c+ Trp53tm1Tyj/Trp53+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
increased medulloblastoma incidence
|
J:102702
|
Cdkn2ctm1Bbd/Cdkn2c+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
increased medulloblastoma incidence
|
J:102702
|
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
increased pituitary adenoma incidence
|
J:63299
|
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
increased pituitary adenoma incidence
|
J:68829
|
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
increased medulloblastoma incidence
|
J:102702
|
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased medulloblastoma incidence
|
J:205254
|
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd Trp53tm1Brn/Trp53tm1Tyj Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:102702
|
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
increased medulloblastoma incidence
|
J:102702
|
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(involves: 129/Sv * C57BL/6 * DBA/2)
|
increased pituitary adenoma incidence
|
J:50053
|
Col4a2em1(IMPC)Wtsi/Col4a2em1(IMPC)Wtsi
(C57BL/6N-Col4a2em1(IMPC)Wtsi/WtsiOulu)
|
increased trigeminal neuroma incidence
|
J:239583
|
Coro1ctm1c(KOMP)Wtsi/Coro1ctm1c(KOMP)Wtsi Ptentm2Mak/Ptentm2Mak Trp53tm1Brn/Trp53tm1Brn Tg(GFAP-cre/Esr1*,-lacZ)ASbk/0
(involves: 129P2/OlaHsd * C57BL/6N * FVB/NJ)
|
increased glioblastoma incidence
|
J:290447
|
Csf2tm1Mlg/Csf2tm1Mlg Ifngtm1Ts/Ifngtm1Ts Il3tm1Glli/Il3tm1Glli
(B6.129S-Csf2tm1Mlg Il3tm1Glli Ifngtm1TsIfngtm1Ts)
|
increased pituitary adenoma incidence
|
J:145518
|
Ctnnb1tm1Mmt/Ctnnb1+ Pik3catm1Gilb/Pik3ca+ Trp53tm1Brn/Trp53+ Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)
|
increased medulloblastoma incidence
|
J:186709
|
Ctnnb1tm1Mmt/Ctnnb1+ Sox2tm1.1(cre/ERT2)Jpmb/Sox2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:201265
|
Ctnnb1tm1Mmt/Ctnnb1+ Trp53tm1Brn/Trp53+ Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)
|
increased medulloblastoma incidence
|
J:186709
|
Cul9tm1.2Yxi/Cul9+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased pituitary gland tumor incidence
|
J:170976
|
Cul9tm1.2Yxi/Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased pituitary gland tumor incidence
|
J:170976
|
Cxcr6tm1Lex/Cxcr6+
(involves: 129S/SvEvBrd * C57BL/6J)
|
increased medulloblastoma incidence
|
J:120952
|
Cxcr6tm1Lex/Cxcr6tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J)
|
increased medulloblastoma incidence
|
J:120952
|
Dmtf1tm1Cjs/Dmtf1+ Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6)
|
increased neurofibroma incidence
|
J:126002
|
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary adenoma incidence
|
J:41857
|
E2f1tm1Njd/E2f1tm1Njd Rb1tm1Tyj/Rb1+
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))
|
increased pituitary gland tumor incidence
|
J:47108
|
E2f4tm1Lees/E2f4+ Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:81082
|
Ehbp1l1tm1a(EUCOMM)Wtsi/Ehbp1l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Ehbp1l1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Foxo3tm1.1Rdp/Foxo3+ Foxo4tm1.1Rdp/Foxo4tm1.1Rdp
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/N)
|
increased pituitary adenoma incidence
|
J:118179
|
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
increased prolactinoma incidence
|
J:118179
|
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp Foxo4tm1.1Rdp/Foxo4tm1.1Rdp
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/N)
|
increased pituitary adenoma incidence
|
J:118179
|
Gas2l2tm1a(KOMP)Wtsi/Gas2l2tm1a(KOMP)Wtsi
(C57BL/6N-Gas2l2tm1a(KOMP)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Gli1tm3(cre/ERT2)Alj/Gli1+ Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
increased medulloblastoma incidence
|
J:139574
|
Gpr37l1tm1.2Gtva/Gpr37l1tm1.2Gtva Ptch1tm1Zim/Ptch1+
(STOCK Gpr37l1tm1.2Gtva Ptch1tm1Zim/Cnrm)
|
increased medulloblastoma incidence
|
J:272049
|
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+ Rb1tm2Brn/Rb1tm2Brn Tg(Gfap-cre)2Brn/0
(either: (involves: 129 * 129P2/OlaHsd * FVB/N) or (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N))
|
increased pituitary gland tumor incidence
|
J:187257
|
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+ Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53tm1Brn Tg(Gfap-cre)2Brn/0
(either: (involves: 129 * 129P2/OlaHsd * FVB/N) or (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N))
|
increased medulloblastoma incidence
|
J:187257
|
increased pituitary gland tumor incidence
|
J:187257
|
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+ Tg(Gfap-cre)2Brn/0
(either: (involves: 129P2/OlaHsd * FVB/N) or (involves: 129P2/OlaHsd * C57BL/6 * FVB/N))
|
increased pituitary gland tumor incidence
|
J:187257
|
Gt(ROSA)26Sortm1(CAG-MYCN,-luc)Jhsc/Gt(ROSA)26Sor+ Tg(Dbh-icre)1Gsc/0
(involves: 129S6/SvEvTac * C57BL/6)
|
increased neuroblastoma incidence
|
J:222527
|
Gt(ROSA)26Sortm1(RICTOR)Jger/Gt(ROSA)26Sortm1(RICTOR)Jger Tg(GFAP-cre)25Mes/0
(involves: 129 * FVB/N)
|
increased glioma incidence
|
J:192206
|
increased oligodendroglioma incidence
|
J:192206
|
Gt(ROSA)26Sortm1(RICTOR)Jger/Gt(ROSA)26Sortm1(RICTOR)Jger Tg(GFAP-cre)25Mes/0 Tg(GFAP-EGFR*,-lacZ)#Agu/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased astrocytoma incidence
|
J:192206
|
increased glioma incidence
|
J:192206
|
increased oligodendroglioma incidence
|
J:192206
|
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+ Hprt1tm1(sb-Onco-Array)Peli/Y
(involves: 129S7/SvEvBrd)
|
increased medulloblastoma incidence
|
J:166283
|
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+ Hprt1tm1(sb-Onco-Array)Peli/Hprt1+
(involves: 129S7/SvEvBrd)
|
increased medulloblastoma incidence
|
J:166283
|
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc2)6057Njen/0
(involves: C3H * C57BL/6)
|
increased medulloblastoma incidence
|
J:102234
|
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc2)6070Njen/0
(involves: C3H * C57BL/6)
|
increased medulloblastoma incidence
|
J:102234
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/? Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
increased medulloblastoma incidence
|
J:114992
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sor+ Hk2tm1.1Uku/Hk2+ Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased medulloblastoma incidence
|
J:210113
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sor+ Hk2tm1.1Uku/Hk2tm1.1Uku Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased medulloblastoma incidence
|
J:210113
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc Olig2tm2(TVA,cre)Rth/Olig2+
(involves: 129 * 129X1/SvJ)
|
increased medulloblastoma incidence
|
J:139574
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc Tg(Atoh1-cre/Esr1*)14Fsh/0
(involves: 129X1/SvJ * FVB/N)
|
increased medulloblastoma incidence
|
J:139574
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc Tg(GFAP-cre)25Mes/0
(involves: 129X1/SvJ * FVB/N)
|
increased medulloblastoma incidence
|
J:139574
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc Tlx3tm1(cre)Qima/Tlx3+
(involves: 129X1/SvJ)
|
increased medulloblastoma incidence
|
J:139574
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm2(EGFP/cre)Alj Pgbd5tm1.1Aken/Pgbd5tm1.1Aken
(involves: 129 * C57BL/6J * C57BL/6NTac * SW)
|
increased medulloblastoma incidence
|
J:346387
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor Ptentm1Mro/Ptentm1Mro Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53tm1Brn
(involves: 129 * 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
increased nervous system tumor incidence
|
J:204385
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor Ptentm1Mro/Ptentm1Mro Slc1a3tm1(cre/ERT2)Mgoe/Slc1a3+ Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJaeSor)
|
increased astrocytoma incidence
|
J:229481
|
increased glioma incidence
|
J:229481
|
increased oligodendroglioma incidence
|
J:229481
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor Ptentm1Mro/Ptentm1Mro Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB)
|
increased astrocytoma incidence
|
J:204385
|
increased glioma incidence
|
J:204385
|
increased oligodendroglioma incidence
|
J:204385
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor Ptentm1Mro/Ptentm1Mro Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJaeSor)
|
increased astrocytoma incidence
|
J:229481
|
increased glioma incidence
|
J:229481
|
increased oligodendroglioma incidence
|
J:229481
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53tm1Brn
(involves: 129 * 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
increased nervous system tumor incidence
|
J:204385
|
Gt(ROSA)26Sortm2(CAG-Lin28b,-luc)Jhsc/Gt(ROSA)26Sor+ Tg(Dbh-icre)1Gsc/0
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
increased neuroblastoma incidence
|
J:241988
|
Gt(ROSA)26Sortm2(myc*T58A)Rcse/Gt(ROSA)26Sortm2(myc*T58A)Rcse Tg(Wap-cre)11738Mam/0
(involves: 129 * C57BL/6 * SJL)
|
increased brain tumor incidence
|
J:169403
|
increased pituitary gland tumor incidence
|
J:169403
|
Gt(ROSA)26Sortm2Thl/Gt(ROSA)26Sor+ Ptentm1Hwu/Ptentm1Hwu Trp53tm1Thl/Trp53tm1Thl Tyrc-Brd/Tyrc-Brd
(involves: 129/Sv * 129S4/SvJae * C57BL/6)
|
increased glioblastoma incidence
|
J:172585
|
Gt(ROSA)26Sortm2Thl/Gt(ROSA)26Sor+ Ptentm1Hwu/Ptentm1Hwu Tyrc-Brd/Tyrc-Brd
(involves: 129/Sv * 129S4/SvJae * C57BL/6)
|
increased glioblastoma incidence
|
J:172585
|
Gt(ROSA)26Sortm3(myc*S62A)Rcse/Gt(ROSA)26Sortm3(myc*S62A)Rcse Tg(Wap-cre)11738Mam/0
(involves: 129 * C57BL/6 * SJL)
|
increased brain tumor incidence
|
J:169403
|
HelqGt(RRF112)Byg/Helq+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pituitary adenoma incidence
|
J:206104
|
HelqGt(RRF112)Byg/HelqGt(RRF112)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pituitary adenoma incidence
|
J:206104
|
Htatip2tm1Hx/Htatip2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased neuroblastoma incidence
|
J:87066
|
Kdm5atm1.1Kael/Kdm5a+ Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N)
|
increased pituitary gland tumor incidence
|
J:175625
|
Kdm5atm1.1Kael/Kdm5atm1.1Kael Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N)
|
increased pituitary gland tumor incidence
|
J:175625
|
Kifbptm1a(KOMP)Wtsi/Kifbptm1a(KOMP)Wtsi
(C57BL/6N-Kifbptm1a(KOMP)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Krastm4Tyj/Kras+ Ptentm1Hwu/Pten+ Tg(Gfap-cre)77.6Mvs/0
(involves: 129S4/SvJae * BALB/c * C57BL/6NHsd)
|
increased neurofibroma incidence
|
J:154673
|
increased neurofibrosarcoma incidence
|
J:154673
|
Lig4tm1Icrf/Lig4tm1Icrf Trp53tm1Tyj/Trp53tm1Tyj
(either: (involves: 129P2/OlaHsd * 129S2/SvPas) or (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ))
|
increased medulloblastoma incidence
|
J:111068
|
Lig4tm1Pmc/Lig4tm1Pmc Trp53tm1Tyj/Trp53+ Xrcc2tm2Pmc/Xrcc2tm2Pmc Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:144617
|
Lig4tm1Pmc/Lig4tm1Pmc Trp53tm1Tyj/Trp53tm1Tyj Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:144617
|
Lig4tm1Pmc/Lig4tm1Pmc Trp53tm1Tyj/Trp53tm1Tyj Xrcc2tm2Pmc/Xrcc2tm2Pmc Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:144617
|
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac)
|
increased medulloblastoma incidence
|
J:157574
|
Men1tm1.1Ctre/Men1+
(involves: 129S6/SvEvTac * FVB/N)
|
increased pituitary adenohypophysis tumor incidence
|
J:133299
|
Men1tm1.1Ctre/Men1+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:120835
|
Men1tm1.1Ctre/Men1+ Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
increased pituitary adenohypophysis tumor incidence
|
J:133299
|
increased pituitary melanotroph tumor incidence
|
J:133299
|
Men1tm1.1Gfk/Men1+
(involves: 129T2/SvEms * C57BL/6)
|
increased pituitary adenoma incidence
|
J:116086
|
increased prolactinoma incidence
|
J:116086
|
Men1tm1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N))
|
increased pituitary adenoma incidence
|
J:67128
|
increased prolactinoma incidence
|
J:67128
|
Men1tm1Gfk/Men1tm1Gfk Tg(Ins2-cre)25Mgn/0
(involves: 129T2/SvEms * C57BL/6 * C57BL/6J * DBA)
|
increased prolactinoma incidence
|
J:89898
|
Men1tm1Rvt/Men1+
(involves: 129 * C57BL/6)
|
increased pituitary adenohypophysis tumor incidence
|
J:191261
|
increased pituitary gland tumor incidence
|
J:191261
|
Men1tm1Zqw/Men1+
(involves: 129/Sv * 129P2/OlaHsd)
|
increased pituitary adenohypophysis tumor incidence
|
J:85302
|
increased prolactinoma incidence
|
J:85302
|
Men1tm2.1Gfk/Men1+
(involves: 129T2/SvEms * C57BL/6)
|
increased pituitary adenoma incidence
|
J:116086
|
Mir34atm1.2Arte/Mir34a+ Tg(Neurod2-Smo*A1)199Jols/0
(involves: C57BL/6 * C57BL/6N)
|
increased medulloblastoma incidence
|
J:221990
|
Mir34atm1.2Arte/Mir34atm1.2Arte Tg(Neurod2-Smo*A1)199Jols/0
(involves: C57BL/6 * C57BL/6N)
|
increased medulloblastoma incidence
|
J:221990
|
Mldhrtm1Zhgn/Mldhrtm1Zhgn Tg(GFAP-cre)25Mes/0
(involves: FVB/N)
|
increased glioblastoma incidence
|
J:303725
|
Morc2aem1(IMPC)Wtsi/Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu)
|
increased trigeminal neuroma incidence
|
J:239583
|
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd)
|
increased brain tumor incidence
|
J:45433
|
Msh2tm1Whl/Msh2tm1Whl Rb1tm1Brd/Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased pituitary adenohypophysis tumor incidence
|
J:79016
|
increased pituitary melanotroph tumor incidence
|
J:79016
|
Ndrg2tm1Kmori/Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
increased brain tumor incidence
|
J:210264
|
Nf1tm1.1Kest/Nf1tm1c(KOMP)Wtsi Tg(Dhh-cre)1Mejr/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N)
|
increased neurofibroma incidence
|
J:234172
|
Nf1tm1c(KOMP)Wtsi/Nf1tm1c(KOMP)Wtsi Tg(Dhh-cre)1Mejr/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * FVB/N)
|
increased neurofibroma incidence
|
J:234172
|
Nf1tm1Fcr/Nf1+ Tg(GFAP-cre)#Gtm/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA)
|
increased glioma incidence
|
J:176586
|
Nf1tm1Fcr/Nf1+ Trp53tm1Brd/Trp53+
(B6.129-Trp53tm1Brd Nf1tm1Fcr)
|
increased brain tumor incidence
|
J:95933
|
Nf1tm1Fcr/Nf1+ Trp53tm1Tyj/Trp53+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
increased neuroblastoma incidence
|
J:58877
|
increased neurofibrosarcoma incidence
|
J:58877
|
Nf1tm1Fcr/Nf1tm1Fcr Trp53tm1Elee/Trp53tm1Elee Tg(GFAP-cre)25Mes/0
(involves: 129S/SvEv * 129S4/SvJae * FVB/N)
|
increased glioma incidence
|
J:149662
|
Nf1tm1Par/Nf1+ Ptentm1Hwu/Pten+ Trp53tm1Elee/Trp53+ Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N)
|
increased astrocytoma incidence
|
J:134611
|
increased brain tumor incidence
|
J:134611
|
Nf1tm1Par/Nf1+ Ptentm1Hwu/Pten+ Trp53tm1Tyj/Trp53+ Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S2/SvPas * 129S4/SvJae * 129X1/SvJ * FVB/N)
|
increased astrocytoma incidence
|
J:134611
|
increased brain tumor incidence
|
J:134611
|
Nf1tm1Par/Nf1+ Trp53tm1Elee/Trp53+ Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N)
|
increased astrocytoma incidence
|
J:134611
|
increased brain tumor incidence
|
J:134611
|
Nf1tm1Par/Nf1+ Trp53tm1Tyj/Trp53+ Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * FVB/N)
|
increased astrocytoma incidence
|
J:134611
|
increased brain tumor incidence
|
J:134611
|
Nf1tm1Par/Nf1tm1Fcr Tg(GFAP-cre)#Gtm/0
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased glioma incidence
|
J:165209
|
Nf1tm1Par/Nf1tm1Par H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased ganglioneuroma incidence
|
J:80323
|
increased gangliosarcoma incidence
|
J:80323
|
Nf1tm1Par/Nf1tm1Par Tg(Mpz-cre)94Imeg/0
(involves: 129S1/Sv * 129X1/SvJ)
|
increased ganglioneuroma incidence
|
J:80323
|
increased gangliosarcoma incidence
|
J:80323
|
Nf1tm1Par/Nf1tm1Par Tg(Pax3-cre)1Joe/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased ganglioneuroma incidence
|
J:80323
|
increased gangliosarcoma incidence
|
J:80323
|
Nf1tm1Par/Nf1tm1Tyj Tg(Mpz-cre)1Brn/0
(involves: 129/Sv * FVB/N)
|
increased neurofibroma incidence
|
J:131914
|
Nf1tm1Tyj/? Nstr1C57BL/6J/Nstr1C57BL/6J Trp53tm1Tyj/?
(involves: 129S2/SvPas * A/J * C57BL/6J)
|
increased neurofibrosarcoma incidence
|
J:105038
|
Nf1tm1Tyj/? Trp53tm1Tyj/? MastrC57BL/6J/?
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6J)
|
increased astrocytoma incidence
|
J:92444
|
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * C57BL/6)
|
increased neurofibrosarcoma incidence
|
J:18542
|
Nf1tm1Tyj/Nf1+ Suz12Gt(Betageo)1Khe/Suz12+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased neurofibroma incidence
|
J:217077
|
increased neurofibrosarcoma incidence
|
J:217077
|
increased Schwannoma incidence
|
J:217077
|
Nf1tm1Tyj/Nf1+ Suz12Gt(Betageo)1Khe/Suz12+ Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased glioma incidence
|
J:217077
|
increased neurofibrosarcoma incidence
|
J:217077
|
Nf1tm1Tyj/Nf1+ Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * BALB/c * C57BL/6J)
|
increased neuroblastoma incidence
|
J:41126
|
Nf1tm1Tyj/Nf1+ Trp53tm1Tyj/Trp53+
(involves: 129/Sv * C57BL/6)
|
increased neurofibrosarcoma incidence
|
J:58876
|
Nf1tm1Tyj/Nf1+ Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas)
|
increased neurofibrosarcoma incidence
|
J:131914
|
Nf1tm1Tyj/Nf1+ Trp53tm1Tyj/Trp53+
(B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)
|
increased astrocytoma incidence
|
J:64364
|
increased brain tumor incidence
|
J:64364
|
increased glioblastoma incidence
|
J:64364
|
Nf1tm1Tyj/Nf1+ Trp53tm1Tyj/Trp53+
((C3H/HeJ x B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)F1)
|
increased astrocytoma incidence
|
J:64364
|
increased brain tumor incidence
|
J:64364
|
increased glioblastoma incidence
|
J:64364
|
Nf1tm1Tyj/Nf1+ Trp53tm1Tyj/Trp53+
((CAST/EiJ x B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)F1)
|
increased astrocytoma incidence
|
J:64364
|
increased brain tumor incidence
|
J:64364
|
increased glioblastoma incidence
|
J:64364
|
Nf1tm1Tyj/Nf1+ Trp53tm1Tyj/Trp53+
((CBA/J x B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)F1)
|
increased brain tumor incidence
|
J:64364
|
Nf1tm1Tyj/Nf1+ Trp53tm1Tyj/Trp53+
((SJL/J x B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)F1)
|
increased astrocytoma incidence
|
J:64364
|
increased brain tumor incidence
|
J:64364
|
increased glioblastoma incidence
|
J:64364
|
Nf1tm1Tyj/Nf1+ Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased glioma incidence
|
J:217077
|
increased neuroblastoma incidence
|
J:217077
|
increased neurofibrosarcoma incidence
|
J:217077
|
Nf1tm1Tyj/Nf1tm2Tyj
(chimera involves: 129S2/SvPas)
|
increased neurofibroma incidence
|
J:58876
|
Nf2tm1Gth/Nf2+
(involves: 129P2/OlaHsd * FVB/N)
|
increased neurofibroma incidence
|
J:63264
|
increased neurofibrosarcoma incidence
|
J:63264
|
Nf2tm1Gth/Nf2tm2Gth Tg(Mpz-cre)#Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased neurofibrosarcoma incidence
|
J:63264
|
increased Schwannoma incidence
|
J:63264
|
Nf2tm2Gth/Nf2+ Trp53tm1Brd/Trp53+ Tg(Mpz-cre)3Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
increased neurofibrosarcoma incidence
|
J:92413
|
Nf2tm2Gth/Nf2+ Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased Schwannoma incidence
|
J:132943
|
Nf2tm2Gth/Nf2tm2Gth
(involves: 129P2/OlaHsd * FVB/N)
|
increased meningioma incidence
|
J:173718
|
Nf2tm2Gth/Nf2tm2Gth Ptgdstm1.1(cre)Gvn/Ptgds+
(involves: 129P2/OlaHsd * FVB/N)
|
increased meningioma incidence
|
J:173718
|
increased pituitary adenoma incidence
|
J:173718
|
Nf2tm2Gth/Nf2tm2Gth Ptgdstm1.1(cre)Gvn/Ptgds+ Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * FVB/N)
|
increased nervous system tumor incidence
|
J:173718
|
Nf2tm2Gth/Nf2tm2Gth Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased neurofibrosarcoma incidence
|
J:92413
|
increased Schwannoma incidence
|
J:63264,
J:92413
|
Nf2tm2Gth/Nf2tm2Gth Tg(Mpz-cre)3Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased neurofibrosarcoma incidence
|
J:63264
|
increased Schwannoma incidence
|
J:63264,
J:92413
|
Nf2tm2Gth/Nf2tm2Gth Tg(Mpz-cre)4Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased Schwannoma incidence
|
J:63264
|
Nf2tm2Gth/Nf2tm2Gth Tg(Mpz-cre)#Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased neurofibrosarcoma incidence
|
J:63264
|
Nf2tm2Gth/Nf2tm2Gth Tg(Postn-cre)1Sjc/0
(involves: 129P2/OlaHsd * FVB/NTac)
|
increased neurofibrosarcoma incidence
|
J:216420
|
increased Schwannoma incidence
|
J:216420
|
Nf2tm2Gth/Nf2tm2Gth Trp53tm1Brd/Trp53+ Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
increased nervous system tumor incidence
|
J:92413
|
increased neurofibroma incidence
|
J:92413
|
increased neurofibrosarcoma incidence
|
J:92413
|
increased Schwannoma incidence
|
J:92413
|
Nf2tm2Gth/Nf2tm2Gth Trp53tm1Brd/Trp53+ Tg(Mpz-cre)3Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
increased neurofibrosarcoma incidence
|
J:92413
|
Nf2tm2Gth/Nf2tm2Gth Trp53tm1Brd/Trp53tm1Brd Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
increased neurofibrosarcoma incidence
|
J:92413
|
Nf2tm2Gth/Nf2tm2Gth Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased Schwannoma incidence
|
J:132943
|
Nf2tm2Gth/Nf2tm2Gth Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased Schwannoma incidence
|
J:132943
|
Nhej1tm1Fwa/Nhej1tm1Fwa Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129)
|
increased medulloblastoma incidence
|
J:138774
|
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Nsun2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Pgbd5tm1.1Aken/Pgbd5tm1.2Aken Ptch1tm1Bjw/Ptch1tm1Bjw Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * C57BL/6J * C57BL/6NTac * FVB/N * SW)
|
increased medulloblastoma incidence
|
J:346387
|
Polbtm1a(KOMP)Wtsi/Polbtm1a(KOMP)Wtsi
(C57BL/6N-Polbtm1a(KOMP)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Pomctm1Low/Pomc+
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased pituitary adenoma incidence
|
J:119240
|
Pomctm1Low/Pomc+ Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster)
|
increased pituitary adenoma incidence
|
J:119240
|
Pomctm1Low/Pomctm1Low
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased pituitary adenoma incidence
|
J:119240
|
Pomctm1Low/Pomctm1Low Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster)
|
increased pituitary adenoma incidence
|
J:119240
|
Prdm2tm1Shg/Prdm2+
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary adenoma incidence
|
J:71406
|
Prdm2tm1Shg/Prdm2tm1Shg
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary adenoma incidence
|
J:71406
|
Prkar1atm1.1Lsk/Prkar1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased Schwannoma incidence
|
J:160299
|
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk Tg(Ghrhr-cre)3242Lsk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased pituitary gland tumor incidence
|
J:130264
|
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk Tg(Tyr-cre)3Gfk/0
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased Schwannoma incidence
|
J:98799
|
Prltm1Hmn/Prltm1Hmn
(involves: 129S2/SvPas)
|
increased pituitary adenoma incidence
|
J:79661
|
Prmt7tm1a(EUCOMM)Wtsi/Prmt7tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Prmt7tm1a(EUCOMM)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Psphtm1a(EUCOMM)Hmgu/Psphtm1a(EUCOMM)Hmgu
(C57BL/6N-Psphtm1a(EUCOMM)Hmgu/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Ptch1tm1.1Hahn/Ptch1+
(involves: 129 * BALB/c * C57BL/6 * FVB/N)
|
increased medulloblastoma incidence
|
J:149148
|
Ptch1tm1Bjw/Ptch1tm1Bjw Tg(Atoh1-cre)1Bfri/0
(involves: 129T2/SvEms * C57BL/6 * CBA)
|
increased medulloblastoma incidence
|
J:139573
|
Ptch1tm1Bjw/Ptch1tm1Bjw Tg(Atoh1-cre/Esr1*)14Fsh/0
(involves: 129T2/SvEms * FVB/N)
|
increased medulloblastoma incidence
|
J:139573
|
Ptch1tm1Bjw/Ptch1tm1Bjw Tg(GFAP-cre)25Mes/0
(involves: 129T2/SvEms * FVB/N)
|
increased medulloblastoma incidence
|
J:139573
|
Ptch1tm1Cklr/Ptch1+ Pax7tm1(cre)Mrc/Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:159972
|
Ptch1tm1Cklr/Ptch1+ Trp53tm1Brn/? Pax7tm1(cre)Mrc/Pax7+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:159972
|
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased medulloblastoma incidence
|
J:205254
|
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased medulloblastoma incidence
|
J:42441
|
Ptch1tm1Mps/Ptch1+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased medulloblastoma incidence
|
J:144811,
J:114992,
J:102702
|
Ptch1tm1Mps/Ptch1+ Ptch2tm1Pmc/Ptch2tm1Pmc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased medulloblastoma incidence
|
J:112118
|
Ptch1tm1Mps/Ptch1+ Tg(Atoh1-GFP)1Jejo/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased medulloblastoma incidence
|
J:144811
|
Ptch1tm1Mps/Ptch1+ Tg(Atoh1-sb11)1Mtay/0 TgTn(sb-T2/Onc3)12740Njen/0
(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6J * ICR)
|
increased medulloblastoma incidence
|
J:181542
|
Ptch1tm1Mps/Ptch1+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129 * 129S2/SvPas * C57BL/6)
|
increased medulloblastoma incidence
|
J:125534
|
Ptch1tm1Zim/Ptch1+
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1))
|
increased medulloblastoma incidence
|
J:47421
|
Ptch1tm1Zim/Ptch1+
(involves: 129 * CD-1)
|
increased medulloblastoma incidence
|
J:79666,
J:165388
|
Ptentm1Rdp/Pten+ Trp53tm1Brn/Trp53tm1Brn Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased astrocytoma incidence
|
J:140704
|
increased glioblastoma incidence
|
J:140704
|
increased glioma incidence
|
J:140704
|
Ptentm2.1Ppp/Pten+ Tg(Cnp-EGFR)10Nrat/0 Tg(Dhh-cre)1Mejr/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL)
|
increased neurofibrosarcoma incidence
|
J:195067
|
Ptentm2.1Ppp/Ptentm2.1Ppp Tg(Cnp-EGFR)10Nrat/0 Tg(Dhh-cre)1Mejr/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL)
|
increased neurofibrosarcoma incidence
|
J:195067
|
Ptentm2.1Ppp/Ptentm2.1Ppp Tg(Dhh-cre)1Mejr/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL)
|
increased neurofibrosarcoma incidence
|
J:195067
|
Ptentm2.1Ppp/Ptentm2.1Ppp Tg(GFAP-TAg121)1Tvd/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2 * FVB/N)
|
increased astrocytoma incidence
|
J:99385
|
Ptentm2Mak/Ptentm2Mak Tg(GFAP-cre/Esr1*,-lacZ)ASbk/0 Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * FVB/NJ)
|
increased glioblastoma incidence
|
J:290447
|
Ptentm2Mak/Ptentm2Mak Trp53tm1Brn/Trp53tm1Brn Tg(Nes-cre/ERT2,-ALPP)1Sbk/0
(involves: 129P2/OlaHsd)
|
increased glioma incidence
|
J:237990
|
increased medulloblastoma incidence
|
J:237990
|
Rag1tm1Mom/Rag1tm1Mom Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL)
|
increased medulloblastoma incidence
|
J:141515
|
increased pituitary adenoma incidence
|
J:141515
|
Rag1tm1Mom/Rag1tm1Mom Trp53tm1Brd/Trp53tm1Brd Xrcc5tm1Dbr/Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL)
|
increased medulloblastoma incidence
|
J:141515
|
Rb1tm1Brd/Rb1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased brain tumor incidence
|
J:2516
|
increased pituitary adenoma incidence
|
J:17434
|
Rb1tm1Brd/Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased pituitary adenohypophysis tumor incidence
|
J:79016
|
increased pituitary melanotroph tumor incidence
|
J:79016
|
Rb1tm1Brn/Rb1+ Tg(Pomc-FLP)1aBrn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased pituitary adenoma incidence
|
J:48860
|
Rb1tm1Brn/Rb1tm1Brn Tg(Pomc-FLP)1aBrn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased pituitary adenoma incidence
|
J:48860
|
Rb1tm1Brn/Rb1tm1Brn X/Tg(Pomc-FLP)1bBrn
(involves: 129P2/OlaHsd * FVB/N)
|
increased pituitary adenoma incidence
|
J:48860
|
Rb1tm1Mlh/Rb1+
(either: 129P2/OlaHsd-Rb1tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))
|
increased pituitary melanotroph tumor incidence
|
J:20542
|
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:81082,
J:2511
|
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6J)
|
increased pituitary adenohypophysis tumor incidence
|
J:133299
|
increased pituitary melanotroph tumor incidence
|
J:133299
|
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N)
|
increased pituitary gland tumor incidence
|
J:175625
|
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas)
|
increased pituitary gland tumor incidence
|
J:215358
|
Rb1tm1Tyj/Rb1+ Rbl1tm1Tyj/Rbl1+
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:34058
|
Rb1tm1Tyj/Rb1+ Rbl1tm1Tyj/Rbl1tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:34058
|
Rb1tm1Tyj/Rb1+ Smarca4tm1Mag/Smarca4+
(involves: 129S/Sv * 129S2/SvPas * C57BL/6J * CD-1)
|
increased pituitary gland tumor incidence
|
J:132091
|
Rb1tm1Tyj/Rb1+ Tg(S100b-v-erbB)4496Waw/0
(involves: 129S2/SvPas * C57BL/6J * DBA/2J * FVB/N)
|
increased glioma incidence
|
J:82649
|
Rb1tm1Tyj/Rb1+ Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * BALB/c * C57BL/6J)
|
increased neuroblastoma incidence
|
J:41126
|
Rb1tm1Tyj/Rb1+ Trim27Gt(XP0484)Wtsi/Trim27Gt(XP0484)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:189317
|
Rb1tm1Tyj/Rb1+ Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary melanotroph tumor incidence
|
J:19542
|
Rb1tm1Tyj/Rb1tm2Tyj
(chimera involves: 129S2/SvPas * C57BL/6)
|
increased pituitary adenoma incidence
|
J:59268
|
Rb1tm2Brn/Rb1tm2Brn Tg(Gfap-cre)2Brn/0
(involves: 129 * FVB/N)
|
increased pituitary gland tumor incidence
|
J:187257
|
Rb1tm2Brn/Rb1tm2Brn Tg(Rbp3-cre)1Brn/0
(involves: 129 * FVB/N)
|
increased pituitary adenohypophysis tumor incidence
|
J:77982
|
increased pituitary melanotroph tumor incidence
|
J:77982
|
Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brd/Trp53tm1Brd Tg(Gfap-cre)2Brn/0
(involves: 129 * 129S7/SvEvBrd * FVB/N)
|
increased medulloblastoma incidence
|
J:61961
|
Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53tm1Brn Tg(Gfap-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased medulloblastoma incidence
|
J:61961
|
Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53tm1Brn Tg(Gfap-cre)2Brn/0
(involves: 129 * 129P2/OlaHsd * FVB/N)
|
increased medulloblastoma incidence
|
J:187257
|
increased pituitary gland tumor incidence
|
J:187257
|
Rb1tm2Mlh/Rb1+
(either: 129P2/OlaHsd-Rb1tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))
|
increased pituitary melanotroph tumor incidence
|
J:20542
|
Rb1tm3Tyj/Rb1tm3Tyj Tg(Nes-cre)1Atp/0
(involves: 129S4/SvJae * FVB/N)
|
increased pituitary gland tumor incidence
|
J:91406
|
Rb1tm3Tyj/Rb1tm3Tyj Trp53tm1Tyj/Trp53tm1Tyj Tg(Nes-cre)1Atp/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N)
|
increased pituitary gland tumor incidence
|
J:91406
|
Rettm2.1Cos/? Tg(Th-MYCN)41Waw/0
(involves: 129S1/Sv * BALB/c * C57BL/6J)
|
increased neuroblastoma incidence
|
J:261033
|
Rettm2.1Cos/Rettm2.1Cos
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
increased ganglioneuroma incidence
|
J:60659
|
Rgsc1033/Rgsc1033+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased pituitary adenoma incidence
|
J:133634
|
Rint1tm1Whl/Rint1+
(Not Specified)
|
increased pituitary adenoma incidence
|
J:122805
|
Rtel1tm2.1Hdin/Rtel1tm2.1Hdin Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
increased medulloblastoma incidence
|
J:202812
|
Smarcb1tm1Gvk/Smarcb1+
(involves: 129/Sv * C57BL/6J * SJL/J)
|
increased brain tumor incidence
|
J:101185
|
Smarcb1tm2Sho/Smarcb1tm2Sho Trp53tm1Brn/Trp53tm1Brn Tg(GFAP-cre)#Gtm/0
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA)
|
increased brain tumor incidence
|
J:226786
|
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac)
|
increased glioma incidence
|
J:166879
|
Ssr2tm1b(EUCOMM)Wtsi/Ssr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ssr2tm1b(EUCOMM)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
SufuGt(XB699)Byg/Sufu+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased medulloblastoma incidence
|
J:125534
|
Tg(AMH-Fshr*D580H)#Hht/0
(involves: FVB/N)
|
increased prolactinoma incidence
|
J:160015
|
Tg(Atoh1-sb11)1Mtay/0 TgTn(sb-T2/Onc3)12740Njen/0 Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C3H * C57BL/6J * ICR)
|
increased medulloblastoma incidence
|
J:181542
|
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0 Tg(Dbh-icre)1Gsc/0
(involves: C57BL/6 * FVB/N)
|
increased neuroblastoma incidence
|
J:186696
|
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0 Tg(Dbh-icre)1Gsc/0 Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6J * FVB/N)
|
increased neuroblastoma incidence
|
J:186696
|
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0 Thtm1(cre)Te/Th+
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
increased neuroblastoma incidence
|
J:186696
|
Tg(CMV-tTA)3Bjd/0 Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL)
|
increased Schwannoma incidence
|
J:95465
|
Tg(Cnp-EGFR)10Nrat/0
(involves: C57BL/6 * SJL)
|
increased neurofibroma incidence
|
J:95933
|
Tg(GFAP-Hras1)2Agu/0
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
increased astrocytoma incidence
|
J:69129
|
Tg(GFAP-Hras1)2Agu/Tg(GFAP-Hras1)2Agu
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
increased astrocytoma incidence
|
J:69129
|
Tg(GFAP-SRC)1Aag/0
(involves: C3H * C57BL/6)
|
increased astrocytoma incidence
|
J:40335
|
Tg(GFAP-SRC)2Aag/0
(involves: C3H * C57BL/6)
|
increased astrocytoma incidence
|
J:40335
|
increased Schwannoma incidence
|
J:40335
|
Tg(GFAP-TAg121)1Tvd/0
(involves: C57BL/6 * DBA/2 * FVB/N)
|
increased astrocytoma incidence
|
J:77132
|
Tg(GFAP-tTA)67Pop/0 Tg(tetO-Ifng)184Pop/0
(B6.Cg-Tg(GFAP-tTA)67Pop Tg(tetO-Ifng)184Pop)
|
increased medulloblastoma incidence
|
J:94092
|
Tg(GFAP-tTA)67Pop/0 Tg(tetO-Ifng)184Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
increased medulloblastoma incidence
|
J:94092
|
Tg(GFAP-TVA)5Hev/0
(involves: BALB/c * C57BL/6 * FVB/N)
|
increased glioma incidence
|
J:125535
|
increased oligodendroglioma incidence
|
J:125535
|
Tg(Gh-Gal)4599Vron/?
(involves: C57BL/6 * CD-1 * SJL)
|
increased pituitary adenoma incidence
|
J:86486
|
Tg(Mdm2)1Snj/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased pituitary adenoma incidence
|
J:51661
|
Tg(Mdm2)1Snj/0 Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased medulloblastoma incidence
|
J:51661
|
Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr)
|
increased pituitary adenoma incidence
|
J:93548
|
Tg(NES-TVA)J12Ech/0
(involves: FVB/N)
|
increased glioma incidence
|
J:125535
|
increased oligodendroglioma incidence
|
J:125535
|
Tg(NES-TVA)J12Ech/0 Trp53tm1Brd/Trp53+
(involves: 129 * C57BL/6 * FVB/N)
|
increased glioma incidence
|
J:52161
|
Tg(Neurod2-Smo*A1)199Jols/0
(C57BL/6-Tg(Neurod2-Smo*A1)199Jols)
|
increased medulloblastoma incidence
|
J:93861
|
Tg(Neurod2-Smo*A1)199Jols/0
(involves: C57BL/6)
|
increased medulloblastoma incidence
|
J:221990
|
Tg(Neurod2-Smo*A1)199Jols/Tg(Neurod2-Smo*A1)199Jols
(C57BL/6-Tg(Neurod2-Smo*A1)199Jols)
|
increased medulloblastoma incidence
|
J:133312,
J:189258
|
Tg(Neurod2-Smo*A2)#Jols/0
(C57BL/6-Tg(Neurod2-Smo*A2)#Jols)
|
increased medulloblastoma incidence
|
J:189258
|
Tg(OMP-SV40T)13Bse/0
(involves: C57BL/6 * SJL)
|
increased neuroblastoma incidence
|
J:54269
|
Tg(Prl-EGFR)#Sme/0
(Not Specified)
|
increased prolactinoma incidence
|
J:219654
|
Tg(PyLT)1Vb/0
(Not Specified)
|
increased pituitary adenoma incidence
|
J:55528
|
increased pituitary gland tumor incidence
|
J:55528
|
Tg(Rbp3-SV40)IT-2Jjw/?
(involves: BALB/c * C57BL/6)
|
increased pineal gland tumor incidence
|
J:60231
|
Tg(RBP3-TAg)#Ove/0
(involves: C57BL/6 * FVB/N)
|
increased brain tumor incidence
|
J:59267
|
Tg(rTH-Tag)20Dmc/0
(involves: C57BL/6NTac * DBA/2NTac)
|
increased brain tumor incidence
|
J:90323
|
increased neuroblastoma incidence
|
J:90323
|
Tg(S100b-v-erbB)4496Waw/0
(involves: C57BL/6J * DBA/2J * FVB/N)
|
increased oligodendroglioma incidence
|
J:82649
|
Tg(S100b-v-erbB)4496Waw/0 Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6J * DBA/2J * FVB/N)
|
increased glioma incidence
|
J:82649
|
increased oligodendroglioma incidence
|
J:82649
|
Tg(S100b-v-erbB)4496Waw/0 Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6J * DBA/2J)
|
increased glioma incidence
|
J:225862
|
increased oligodendroglioma incidence
|
J:225862
|
Tg(Slc1a2-tTA)#Waw/0 Tg(tetO-MYCN,-luc)#Waw/0
(involves: FVB/NJ)
|
increased medulloblastoma incidence
|
J:160518
|
Tg(Slc1a2-tTA)#Waw/0 Tg(tetO-MYCN,-luc)#Waw/Tg(tetO-MYCN,-luc)#Waw
(involves: FVB/NJ)
|
increased medulloblastoma incidence
|
J:160518
|
Tg(SV)7Bri/0
(C57BL/6J-Tg(SV)7Bri/J)
|
increased brain tumor incidence
|
J:94307
|
Tg(SV)419Bri/Tg(SV)419Bri
(C57BL/6J-Tg(SV)419Bri)
|
increased brain tumor incidence
|
J:147031
|
Tg(SV)427Bri/0
(C57BL/6J-Tg(SV)427Bri)
|
increased brain tumor incidence
|
J:79096,
J:147031
|
Tg(tetO-TAg)2-5Hiwa/0
(involves: C57BL/6)
|
increased neuroblastoma incidence
|
J:156984,
J:175962
|
Tg(tetO-TAg,CMV-rtTA)123Yihu/0
(involves: FVB/N)
|
increased medulloblastoma incidence
|
J:141623
|
Tg(Th-ALK*F1174L)2Loch/0 Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6J * CBA)
|
increased neuroblastoma incidence
|
J:191012
|
Tg(Th-MYCN)41Waw/0
(involves: BALB/c * C57BL/6J)
|
increased neuroblastoma incidence
|
J:41126
|
Tg(Th-MYCN)41Waw/0
(involves: BALB/c * C57BL/6J * FVB/N)
|
increased neuroblastoma incidence
|
J:41126
|
Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6J)
|
increased neuroblastoma incidence
|
J:172448
|
Tg(Th-MYCN)41Waw/0 Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6J * FVB/N)
|
increased neuroblastoma incidence
|
J:41126
|
Tg(Th-MYCN)41Waw/Tg(Th-MYCN)41Waw
(involves: BALB/c * C57BL/6J)
|
increased neuroblastoma incidence
|
J:41126
|
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
increased pituitary adenoma incidence
|
J:95391
|
Trim37Gt(RRO307)Byg/Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg)
|
increased medulloblastoma incidence
|
J:232482
|
Trp53Bbl/Trp53+
(C57BL/6JSfdAnu-Trp53Bbl/Anu)
|
increased brain tumor incidence
|
J:104190
|
Trp53bhy/Trp53+
(C57BL/6JSfdAnu-Trp53bhy/Anu)
|
increased brain tumor incidence
|
J:104190
|
Trp53tm1Brd/Trp53tm1Brd Xrcc4tm2.1Fwa/Xrcc4tm2Fwa Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:109585
|
Trp53tm1Brd/Trp53tm1Brd Xrcc5tm1Dbr/Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL)
|
increased medulloblastoma incidence
|
J:141515
|
Trp53tm1Brn/Trp53tm1Brn Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased astrocytoma incidence
|
J:140704
|
Trp53tm1Brn/Trp53tm1Brn Tg(Nes-cre/ERT2,-ALPP)1Sbk/0
(involves: 129P2/OlaHsd)
|
increased brain tumor incidence
|
J:237990
|
increased medulloblastoma incidence
|
J:237990
|
Trp53tm1Brn/Trp53tm1Tyj Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:102702
|
Trp53tm1Elee/Trp53tm1Elee Tg(GFAP-cre)25Mes/0
(involves: 129S4/SvJae * FVB/N)
|
increased glioma incidence
|
J:149662
|
increased medulloblastoma incidence
|
J:149662
|
Trp53tm1Elee/Trp53tm1Tyj Tg(GFAP-cre)25Mes/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N)
|
increased glioma incidence
|
J:149662
|
increased medulloblastoma incidence
|
J:149662
|
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas)
|
increased medulloblastoma incidence
|
J:102702
|
Trp53tm1Tyj/Trp53tm1Tyj Xrcc2tm1Pmc/Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
increased medulloblastoma incidence
|
J:111068
|
Trp53tm1Tyj/Trp53tm1Tyj Xrcc2tm2Pmc/Xrcc2tm2Pmc Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:144617
|
Xpnpep1tm1a(KOMP)Wtsi/Xpnpep1tm1a(KOMP)Wtsi
(C57BL/6N-Xpnpep1tm1a(KOMP)Wtsi/Wtsi)
|
increased trigeminal neuroma incidence
|
J:239583
|
Xrcc1tm1Pmc/Xrcc1tm1Pmc Trp53tm1Tyj/Trp53+ Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:152528
|
Xrcc1tm1Pmc/Xrcc1tm1Pmc Trp53tm1Tyj/Trp53tm1Tyj Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL)
|
increased medulloblastoma incidence
|
J:152528
|